Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reimbursement Briefs: OIG, CMS Address DME; Cigna Genetic Testing Policy Takes Effect

This article was originally published in The Gray Sheet

Executive Summary

OIG released reports pressing for reduced Medicaid payments on DME. Meanwhile, CMS delayed again the face-to-face requirement for DME reimbursement and updated its oxygen supplier policy. A new policy at insurer Cigna took effect to require genetic counseling prior to genetic testing for certain conditions.


Related Content

Bill Would Stop Medicare Payments To Unlicensed Orthotics Providers
Clinical Lab And DME Payments Face Cuts Under Obama Budget
CMS To Pay Co-Surgeons For Transcatheter Valve Procedures, But At Lower Value Than Sought By Physicians


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts